ARTES and Minapharm joint forces
ARTES Biotechnology GmbH, Germany, and Minapharm Pharmaceuticals and Chemical Industries S.A.E., Egypt, jointly announce…
ARTES Biotechnology GmbH, Germany, and Minapharm Pharmaceuticals and Chemical Industries S.A.E., Egypt, jointly announce…
On the occasion of its 20th anniversary, ProBioGen AG announced to invest 20€ million and to double its workforce. CEO D…
On the occasion of its 20th anniversary, ProBioGen AG announced to invest 20€ million and to double its workforce. CEO D…
Anlässlich des 20-jährigen Bestehens der ProBioGen AG begrüßte der Vorstandsvorsitzende Dr. Wieland Wolf am 4. September…
Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG announced today: The U.S. Food and Drug Adm…
Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG announced today: Patient recruitment for th…
Proteo, Inc. (OTCQB: PTEO; Freiverkehr Frankfurt: WKN: 925981) and its wholly-owned subsidiary Proteo Biotech AG announc…
Proteo, Inc. (OTCQB: PTEO; Freiverkehr Frankfurt: WKN: 925981) and its wholly-owned subsidiary Proteo Biotech AG announc…
Proteo, Inc. (OTCQB: PTEO; Freiverkehr Frankfurt: WKN: 925981) and its wholly-owned subsidiary Proteo Biotech AG announc…
Die Proteo, Inc. (OTCQB: PTEO; Freiverkehr Frankfurt: WKN: 925981) und ihre 100-prozentige Tochtergesellschaft Proteo Bi…